AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 77993
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment application
Trial: 23641793
Drug: Oral levofloxacin
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral levofloxacin 500 mg 1*1 for 21 days
Trial: 17218327
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy plus ultrasound (US)
Trial: 17218327
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy plus placebo ultrasound (placebo US)
Trial: 11145762
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (biventricular pacing)
Trial: 8240146
Drug: Intravenous aminophylline
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous aminophylline infusion adjusted to maintain therapeutic levels.
Trial: 8240146
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups received nebulised salbutamol and ipratropium bromide, intravenous hydrocortisone, and oxygen.
Trial: 3927692
Drug: CoQ10 (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CoQ10 (150 mg/day in 3 daily doses) for 4 weeks
Trial: 26681678
Drug: trabectedin 1.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: trabectedin 1.3 mg/mq i.v. q 3 weeks
Trial: 17549328
Drug: Intramuscular stimulation
RxNorm normalized name: follicle stimulating hormone / luteinizing hormone Injection [Menopur]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular stimulation
Trial: 15308432
Drug: Antianginal medications
RxNorm normalized name: ANTIANGINALS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antianginal medications (beta-blockers, calcium antagonists, long-acting nitrates)
Trial: 15308432
Drug: Antianginal medications
RxNorm normalized name: ANTIANGINALS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antianginal medications prescribed
Trial: 9842806
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion 100 microg kg(‐1) min(‐1) (n = 29)
Trial: 7695326
Drug: Fluconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (400 mg/day)
Trial: 162672
Drug: ibuprofen (900‐1800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibuprofen (900‐1800 mg/day)
Trial: 162672
Drug: indomethacin (75‐150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: indomethacin (75‐150 mg/day)
Trial: 19013758
Drug: Daily 16-week
RxNorm normalized name: futibatinib
DrugBank: Futibatinib (DB15149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily 16-week home-based hand exercise
Trial: 16625231
Drug: Cabergoline (0.5‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (0.5‐1 mg weekly for 6 months)
Trial: 11769817
Drug: Clozapine 6
RxNorm normalized name: clozapine 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine 6 mg
Trial: 11769817
Drug: Clozapine 3
RxNorm normalized name: clozapine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine 3 mg
Trial: 11769817
Drug: Clozapine 3
RxNorm normalized name: clozapine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine 3 mg and 6 mg
Trial: 9231677
Drug: External irradiation
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External irradiation alone (planned dose 60 Gy)
Trial: 8220800
Drug: Double-blind placebo-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-blind placebo-controlled challenge with gelatine capsules
Trial: 3690941
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg acetaminophen plus 60 mg codeine
Trial: 22898215
Drug: Adalimumab (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab (40 mg every other week for 12 weeks)
Trial: 21116022
Drug: n-3 long-chain
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 long-chain polyunsaturated fatty acids (LCPUFA) supplementation (600 mg EPA and 400 mg DHA)
Trial: 15674155
Drug: Standard parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard parenteral antibiotics for 2 weeks followed by oral antibiotics for 4 weeks (Group I)
Trial: 10765510
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 gel in the morning
Trial: 10765510
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 gel in the evening
Trial: 8774203
Drug: Ardeparin (low-molecular-weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ardeparin (low-molecular-weight heparin), 0.005 mL/kg (50 anti-Xa U/Kg), administered subcutaneously twice daily for 14 days or until discharge.
Trial: 8774203
Drug: Placebo (graduated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (graduated compression stockings alone), administered subcutaneously twice daily for 14 days or until discharge.
Trial: 8774203
Drug: Ardeparin (low-molecular-weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ardeparin (low-molecular-weight heparin)
Trial: 6338868
Drug: 4',6-Dichloroflavan (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4',6-Dichloroflavan (1 mg/kg, 3 times per day for 3 doses before and 13 doses after challenge)
Trial: 25549767
Drug: Planning-focused cognitive
RxNorm normalized name: Plan B One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Planning-focused cognitive behavioral therapy (CBT)
Trial: 25549767
Drug: Solution-focused treatment
RxNorm normalized name: undecylenate Topical Solution [Hongo Killer Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution-focused treatment (SFT)
Trial: 21816474
Drug: Comparison group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison group (monthly case management plus referrals to community services)
Trial: 18070948
Drug: Cooled ablation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooled ablation (open irrigation at 15 ml/min, 45 degrees C, 35 (5) W)
Trial: 12373659
Drug: Gabapentin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (up to 1,800 mg/day)
Trial: 2402214
Drug: Inosine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inosine supplementation (6,000 mg.d‐1 for 2 d)
Trial: 7446607
Drug: Intrauterine irrigation
RxNorm normalized name: Intrauterine System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine irrigation with cefamandole nafate solution
Trial: 7446607
Drug: Irrigation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irrigation with normal saline solution
Trial: 26860124
Drug: Vorapaxar monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorapaxar monotherapy
Trial: 20412603
Drug: Single 200,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 200,000 IU vitamin A capsule administration
Trial: 19227864
Drug: Diet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet therapy containing a specialized product enriched with vitamins and minerals (50% calcium, 20% protein, 17-60% of 11 minerals, and 11 vitamins)
Trial: 15704058
Drug: Bosentan (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bosentan (500 mg twice daily, titrated slowly or rapidly)
Trial: 15846939
Drug: Cuban trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cuban trivalent inactivated vaccine against human leptospirosis (vax‐SPIRAL)
Trial: 15846939
Drug: Russian-made vaccine
RxNorm normalized name: Russian thistle pollen extract
DrugBank: Salsola kali pollen (DB10388)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Russian-made vaccine
Trial: 10350029
Drug: Alprazolam 2
RxNorm normalized name: alprazolam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam 2 mg during the midluteal phase of the menstrual cycle
Trial: 10350029
Drug: Alprazolam 2
RxNorm normalized name: alprazolam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam 2 mg during the midfollicular phase of the menstrual cycle
Trial: 1760833
Drug: Intravenous isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous isosorbide dinitrate (ISDN) at a dose of 10 mg/h over the first 3 days of infarction
Trial: 1760833
Drug: Anticoagulants only
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulants only
Trial: 7333402
Drug: 8-methoxypsoralen solution
RxNorm normalized name: 8-methoxypsoralen
DrugBank: Methoxsalen (DB00553)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8-methoxypsoralen solution
Trial: 7333402
Drug: Commercial solid
RxNorm normalized name: Corydalis solida whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial solid formulations of 8-methoxypsoralen
Trial: 31359271
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of oral risperidone
Trial: 31359271
Drug: Dose adjustment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose adjustment of risperidone by -25% for poor metabolizers and by -10% for intermediate metabolizers
Trial: 19090549
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement containing EPA (33 patients)
Trial: 10720131
Drug: Interferon (IFN)
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (IFN) alfa treatment
Trial: 1413984
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acids (0; 1.12; 2.24; 3.37 g n-3 FA/day)
Trial: 1413984
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acids (3.37 g n-3 FA/day)
Trial: 3863197
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg PGE2 triacetin gel administered twice over a 12 hour period
Trial: 3863197
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg PGE2 triacetin gel administered as a single dose
Trial: 21940729
Drug: Eplerenone therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone therapy for 24 weeks
Trial: 19423946
Drug: 1,800 mg
RxNorm normalized name: daratumumab-hyaluronidase-fihj 1,800 mg-30,000 unit/15 mL SUBCUT VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,800 mg of eicosapentaenoic acid (EPA) + statin
Trial: 14628190
Drug: Zydis Selegiline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zydis Selegiline 5 mg
Trial: 8061382
Drug: Triple-dose gadoteridol
RxNorm normalized name: Gadoteridol
DrugBank: Gadoteridol (DB00597)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triple-dose gadoteridol (0.3 mmol/kg total: 0.1 mmol/kg + 0.2 mmol/kg)
Trial: 8061382
Drug: Single-dose gadoteridol
RxNorm normalized name: Gadoteridol
DrugBank: Gadoteridol (DB00597)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose gadoteridol (0.1 mmol/kg)
Trial: 31741283
Drug: Preservative-free hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-free hydrocortisone 0.335% for 12 days four times daily followed by 2 days twice daily instillation (intense treatment group)
Trial: 31741283
Drug: Preservative-free hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-free hydrocortisone 0.335% for 8 days three times daily followed by 3 days twice daily treatment (standard treatment group)
Trial: 28612179
Drug: CT-P10 1000
RxNorm normalized name: Tums 750 MG 8 ct - 1000 72 ct Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT-P10 1000 mg
Trial: 28612179
Drug: RTX 1000
RxNorm normalized name: RTX
DrugBank: Resiniferatoxin (DB06515)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTX 1000 mg
Trial: 26730183
Drug: Tiotropium (TIO)
DrugBank: Tiotropium (DB01409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium (TIO) 18 mcg
Trial: 18771373
Drug: Clarithromycin, 500
RxNorm normalized name: Clarithromycin, 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin, 500 mg, every 12 hours for six doses
Trial: 12204968
Drug: Efavirenz (EFV)
RxNorm normalized name: Efavirenz
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Efavirenz (EFV) 600 mg/day, Nelfinavir (NFV) 750 mg three times daily, Stavudine (d4T) 30 or 40 mg twice daily
Trial: 12204968
Drug: Efavirenz (EFV),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efavirenz (EFV), Nelfinavir (NFV), and Stavudine (d4T) therapy
Trial: 9097333
Drug: Structured empowerment
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured empowerment programme with a trained psychologist during 20 weekly 1-hour sessions
Trial: 8412364
Drug: Butyrate suppositories
RxNorm normalized name: butyrate
DrugBank: Butyric Acid (DB03568)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butyrate suppositories
Trial: 8412364
Drug: Glutamine suppositories
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine suppositories
Trial: 8412364
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conventional therapy for pouchitis discontinued)
Trial: 24398824
Drug: Quetiapine extended-release
RxNorm normalized name: Quetiapine Extended-Release Tablets
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine extended-release (XR) (50 to 300 mg daily)
Trial: 24398824
Drug: Amitriptyline (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (10 to 75 mg daily)
Trial: 25653826
Drug: Quetiapine extended-release
RxNorm normalized name: Quetiapine Extended-Release Tablets
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine extended-release (XR)
Trial: 22349808
Drug: Amuvatinib LSC
RxNorm normalized name: Amuvatinib
DrugBank: Amuvatinib (DB12742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amuvatinib LSC (single-dose)
Trial: 22349808
Drug: Amuvatinib LSC
RxNorm normalized name: Amuvatinib
DrugBank: Amuvatinib (DB12742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amuvatinib LSC 300 mg every 8 h (multiple-dose)
Trial: 20297950
Drug: Fenofibrate (145
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate (145 mg NanoCrystal tablet)
Trial: 20597872
Drug: Low-dose transpupillary
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose transpupillary thermotherapy (TTT)
Trial: 15664306
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (8 g per day)
Trial: 15664306
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (placebo, 8 g per day)
Trial: 12452875
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream 3 days per week with occlusion
Trial: 12452875
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream 3 days per week without occlusion
Trial: 10328192
Drug: Topical sucralfate
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical sucralfate 4 times a day for 3 months
Trial: 7585833
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (20 g daily for 10 days)
Trial: 8417865
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 2 mg daily
Trial: 8417865
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 2 mg daily after placebo
Trial: 3542091
Drug: Deflazacort (DFL)
DrugBank: Deflazacort (DB11921)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Deflazacort (DFL) 24 mg/day
Trial: 3542091
Drug: Prednisone (Pd)
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone (Pd) 20 mg/day
Trial: 19842011
Drug: Modafinil (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (titrated up to a maximum of 400 mg/day over 4 weeks)
Trial: 16022951
Drug: 10-microg dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-microg dose in the 30-day release group
Trial: 16022951
Drug: 30-microg dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-microg dose in the 30-day release group
Trial: 12459617
Drug: Atraumatic restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atraumatic restorative treatment (ART) using glass-ionomer
Trial: 9550353
Drug: CDP-choline (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP-choline (500 mg daily for 10 days every six months)
Trial: 9550353
Drug: CDP-choline plus
RxNorm normalized name: CDP-choline
DrugBank: Citicoline (DB12153)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP-choline plus one hour of occlusion daily
Trial: 9550353
Drug: One hour
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One hour of occlusion daily
Trial: 1835334
Drug: Surgery plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery plus two preoperative and three postoperative intralesional injections of triamcinolone
Trial: 1835334
Drug: Surgery plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery plus oral colchicine (1.2 mg per day) initiated 3 weeks after surgery and continued for 5 months
Trial: 7027655
Drug: Topical Clobetasol-17-propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Clobetasol-17-propionate
Trial: 7027655
Drug: Other topical
RxNorm normalized name: Other topical products for joint and muscular pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other topical corticoids
Trial: 28793974
Drug: GSK561679 (CRF1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK561679 (CRF1 receptor antagonist)
Trial: 25855926
Drug: Urinary kallidinogenase
RxNorm normalized name: kallidinogenase
DrugBank: Kallidinogenase (DB13197)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary kallidinogenase (0.15 PNAU/d, for 7 days) after rt‐PA (0.9 mg/kg)
Trial: 25855926
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received rt‐PA (0.9 mg/kg)
Trial: 11703991
Drug: Eptifibatide (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eptifibatide (0.75 dose)
Trial: 11703991
Drug: Eptifibatide (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eptifibatide (0.5 dose)
Trial: 9743925
Drug: Heparin 2
RxNorm normalized name: heparin 2 units/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin 2 U/ml saline flush solution
Trial: 9743925
Drug: Heparin 10
RxNorm normalized name: heparin 10 units/mL injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin 10 U/ml saline flush solution
Trial: 9743925
Drug: Saline flush
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline flush solution
Trial: 23759263
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg ALA-P plus 1.8 mg iron
Trial: 18391135
Drug: Ondansetron (0.50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (0.50 mg)
Trial: 18391135
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of naltrexone and ondansetron
Trial: 16670166
Drug: T(4)‐T(3) combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T(4)‐T(3) combination therapy
Trial: 11093363
Drug: Iloperidone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iloperidone (8 mg/day to 32 mg/day)
Trial: 1433880
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anesthesia with droperidol, fentanyl and ketamine (DFK)
Trial: 2987601
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg megestrol acetate (MA)
Trial: 2987601
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg megestrol acetate (MA)
Trial: 2987601
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg megestrol acetate (MA)
Trial: 2987601
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg megestrol acetate (MA)
Trial: 2987601
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) equivalent dosages 1000-1500 mg
Trial: 24576857
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) supplementation (1200 mg·d)